Literature DB >> 23930227

Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.

Jonathan R Stevens, Timothy E Wilens, Theodore A Stern.   

Abstract

Entities:  

Year:  2013        PMID： 23930227      PMCID： PMC3733520          DOI： 10.4088/PCC.12f01472

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  95 in total

1.  Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Authors:  David J Posey; Michael G Aman; James T McCracken; Lawrence Scahill; Elaine Tierney; L Eugene Arnold; Benedetto Vitiello; Shirley Z Chuang; Mark Davies; Yaser Ramadan; Andrea N Witwer; Naomi B Swiezy; Pegeen Cronin; Bhavik Shah; Deirdre H Carroll; Christopher Young; Courtney Wheeler; Christopher J McDougle
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

2.  Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.

Authors:  K D Gadow; J Sverd; J Sprafkin; E E Nolan; S Grossman
Journal:  Arch Gen Psychiatry       Date:  1999-04

3.  Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.

Authors:  Russell E Scheffer; Robert A Kowatch; Thomas Carmody; A John Rush
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

4.  Daily methylphenidate use slows the growth of children: a community based study.

Authors:  Megan C Lisska; Scott A Rivkees
Journal:  J Pediatr Endocrinol Metab       Date:  2003-06       Impact factor: 1.634

5.  Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.

Authors:  Hao-Jie Zhu; Kennerly S Patrick; Hong-Jie Yuan; Jun-Sheng Wang; Jennifer L Donovan; C Lindsay DeVane; Robert Malcolm; Julie A Johnson; Geri L Youngblood; Douglas H Sweet; Taimour Y Langaee; John S Markowitz
Journal:  Am J Hum Genet       Date:  2008-05-15       Impact factor: 11.025

Review 6.  Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?

Authors:  John S Markowitz; Kennerly S Patrick
Journal:  J Clin Psychopharmacol       Date:  2008-06       Impact factor: 3.153

7.  Medication use in US youth with mental disorders.

Authors:  Kathleen R Merikangas; Jian-ping He; Judith Rapoport; Benedetto Vitiello; Mark Olfson
Journal:  JAMA Pediatr       Date:  2013-02       Impact factor: 16.193

8.  Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.

Authors:  William J Barbaresi; Slavica K Katusic; Robert C Colligan; Amy L Weaver; Cynthia L Leibson; Steven J Jacobsen
Journal:  J Dev Behav Pediatr       Date:  2006-02       Impact factor: 2.225

9.  Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers.

Authors:  D R Jasinski; S Krishnan
Journal:  J Psychopharmacol       Date:  2008-07-17       Impact factor: 4.153

10.  Comparing the efficacy of medications for ADHD using meta-analysis.

Authors:  Stephen V Faraone; Joseph Biederman; Thomas J Spencer; Megan Aleardi
Journal:  MedGenMed       Date:  2006-10-05
View more
  13 in total

1.  How physician obesity medicine specialists treated obesity before 2012 new drug approvals.

Authors:  Stacy L Schmidt; David Bryman; Frank L Greenway; Ed J Hendricks
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

2.  Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students.

Authors:  Timothy E Wilens; MaryKate Martelon; Amy Yule; Tamar A Kaminski; Colin Burke; Ty S Schepis; Sean E McCabe
Journal:  Am J Addict       Date:  2020-05-20

Review 3.  Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Authors:  Sarah C O S Padilha; Suzane Virtuoso; Fernanda S Tonin; Helena H L Borba; Roberto Pontarolo
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-19       Impact factor: 4.785

4.  Stimulants Do Not Increase the Risk of Seizure-Related Hospitalizations in Children with Epilepsy.

Authors:  Xinyue Liu; Paul R Carney; Regina Bussing; Richard Segal; Linda B Cottler; Almut G Winterstein
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-10-13       Impact factor: 2.576

5.  Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.

Authors:  Maxim Lemelin; Takoua Boukhris; Jin-Ping Zhao; Odile Sheehy; Anick Bérard
Journal:  Pharmacol Res Perspect       Date:  2021-05

Review 6.  Off-label drugs for weight management.

Authors:  Ed J Hendricks
Journal:  Diabetes Metab Syndr Obes       Date:  2017-06-10       Impact factor: 3.168

7.  Real-time fMRI neurofeedback in adolescents with attention deficit hyperactivity disorder.

Authors:  Analucia A Alegria; Melanie Wulff; Helen Brinson; Gareth J Barker; Luke J Norman; Daniel Brandeis; Daniel Stahl; Anthony S David; Eric Taylor; Vincent Giampietro; Katya Rubia
Journal:  Hum Brain Mapp       Date:  2017-03-25       Impact factor: 5.038

8.  Functional connectivity changes associated with fMRI neurofeedback of right inferior frontal cortex in adolescents with ADHD.

Authors:  K Rubia; M Criaud; M Wulff; A Alegria; H Brinson; G Barker; D Stahl; V Giampietro
Journal:  Neuroimage       Date:  2018-12-01       Impact factor: 6.556

Review 9.  Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters.

Authors:  Alaa M Hamed; Aaron J Kauer; Hanna E Stevens
Journal:  Front Psychiatry       Date:  2015-11-26       Impact factor: 4.157

10.  Treatment of Children and Adolescents with Epilepsy with Atomoxetine.

Authors:  Kee Jeong Park; Hyunji Ahn; Mi-Sun Yum; Tae-Sung Ko; Hyo-Won Kim
Journal:  Psychiatry Investig       Date:  2020-04-17       Impact factor: 2.505
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.